Naveris has created highly sensitive blood examinations for tumors to facilitate early detection in the general asymptomatic population, real-time tracking of progress in patients receiving therapy, and identification of cancer reappearance in patients in remission. Our examinations utilize innovative internal technology to capture and examine cancer-related DNA in blood plasma with heightened sensitivity in comparison to current circulating tumor DNA tests.